Erste Asset Management’s Takeda Pharmaceutical TAK Stock Holding History

Erste Asset Management’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$68.2K	Hold	3,674	–	–	﹤0.01%	578
2026 Q1	$68.1K	Hold	3,674	–	–	﹤0.01%	585
2025 Q4	$57.3K	Hold	3,674	–	–	﹤0.01%	582
2025 Q3	$53.8K	Hold	3,674	–	–	﹤0.01%	597
2025 Q2	$56.8K	Hold	3,674	–	–	﹤0.01%	851
2025 Q1	$2.36K	Hold	3,674	–	–	﹤0.01%	526
2024 Q4	$2K	Hold	3,674	–	–	﹤0.01%	532
2024 Q3	$52.2K	Buy	+3,674	New	+$52.1K	﹤0.01%	512
2023 Q3	–	Sell	-3,674	Closed	-$57.7K	–	581
2023 Q2	$57.7K	Hold	3,674	–	–	﹤0.01%	529
2023 Q1	$60.1K	Buy	+3,674	New	+$58.5K	﹤0.01%	546
2022 Q4	–	Sell	-3,674	Closed	-$47.7K	–	593
2022 Q3	$47.7K	Hold	3,674	–	–	﹤0.01%	532
2022 Q2	$50.9K	Hold	3,674	–	–	﹤0.01%	547
2022 Q1	$52.6K	Hold	3,674	–	–	﹤0.01%	533
2021 Q4	$49.9K	Hold	3,674	–	–	﹤0.01%	517
2021 Q3	$60.2K	Hold	3,674	–	–	﹤0.01%	493
2021 Q2	$61.8K	Hold	3,674	–	–	﹤0.01%	486
2021 Q1	$67.1K	Hold	3,674	–	–	﹤0.01%	471
2020 Q4	$66.8K	Hold	3,674	–	–	﹤0.01%	463
2020 Q3	$65.5K	Hold	3,674	–	–	﹤0.01%	416
2020 Q2	$65.9K	Hold	3,674	–	–	﹤0.01%	392
2020 Q1	$55.8K	Hold	3,674	–	–	﹤0.01%	371
2019 Q4	$72.5K	Hold	3,674	–	–	﹤0.01%	376
2019 Q3	$63.2K	Buy	+3,674	New	+$63.5K	﹤0.01%	371

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Erste Asset Management's TAK Position: Q2 2026 in Review

Erste Asset Management held its Takeda Pharmaceutical (TAK) position steady in Q2 2026 at 3,674 shares worth $68.2K. The position accounts for ﹤0.01% of the portfolio, ranked #578.

Erste Asset Management first reported a position in TAK in Q3 2019 and has held it in 23 quarters since. The position peaked at $72.5K in Q4 2019. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Erste Asset Management held 3,674 shares of Takeda Pharmaceutical worth $68.2K as of Q2 2026.
Erste Asset Management left its Takeda Pharmaceutical share count unchanged in Q2 2026.
Takeda Pharmaceutical made up ﹤0.01% of Erste Asset Management's portfolio in Q2 2026, its #578 holding.
Erste Asset Management first reported a position in Takeda Pharmaceutical in Q3 2019 and has held it in 23 quarters since.
Erste Asset Management's Takeda Pharmaceutical position peaked at $72.5K in Q4 2019.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.